CHAVEZ R. MARTIN - 01 Apr 2024 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
01 Apr 2024
Net transactions value
$0
Form type
4
Filing time
03 Apr 2024, 17:43:13 UTC
Previous filing
04 Jan 2024
Next filing
18 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +2,001 +3.4% $0.000000 60,078 01 Apr 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were issued pursuant to Issuer's Outside Director Compensation Policy.